RESOURCES
Company News
Learn about Huateng's latest developments, industry news, and research findings
Industry News
Tumor Xenograft Models in Cancer Research: The "Miniature Battlefield" in Mice
HuaTeng explore the role of CDX and syngeneic tumor models in preclinical cancer research. Learn how xenograft models using immunodeficient mice help evaluate chemotherapy and targeted therapies, while syngeneic models in immunocompetent mice support immuno-oncology discovery. Accelerate your drug development pipeline with validated in vivo platforms.
